Home
About Us
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
Archive
My bio page
Edit user profile
Signature
Reset the password
Home
About Us
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
Archive
A peer-reviewed protocol journal. No publication fee; no access fee.
Search
Overview
Published
Edited
Reviewed
Following
Feedback
Q&A
Makoto Takeda
Department of VirologyIII, National Institute of Infectious Diseases, Japan
2 protocols
Kiyoko Okamoto
Department of VirologyIII, National Institute of Infectious Diseases, Japan, Japan,
1 protocol
Yoshio Mori
Department of VirologyIII, National Institute of Infectious Diseases, Japan, Japan,
1 protocol
Masafumi Sakata
Department of VirologyIII, National Institute of Infectious Diseases, Japan, Japan,
1 protocol
View all coauthors >
Noriyuki Otsuki
Department of VirologyIII, National Institute of Infectious Diseases, Japan
Research focus
Microbiology
Contributions
2
Author merit
Reviewer merit
Editor merit
2 Protocols published
Analysis of the Effect of Sphingomyelinase on Rubella Virus Infectivity in Two Cell Lines
Authors:
Noriyuki Otsuki
,
Masafumi Sakata
,
Yoshio Mori
,
Kiyoko Okamoto
and
Makoto Takeda
,
date:
09/05/2018,
view:
3086,
Q&A:
0
Rubella is a mildly contagious disease characterized by low-grade fever and a morbilliform rash caused by the rubella virus (RuV). Viruses often use cellular phospholipids for infection. We studied the roles of cellular sphingomyelin in RuV ...
More >
Liposome Flotation Assay for Studying Interactions Between Rubella Virus Particles and Lipid Membranes
Authors:
Kyoko Saito
,
Noriyuki Otsuki
,
Makoto Takeda
and
Kentaro Hanada
,
date:
08/20/2018,
view:
5583,
Q&A:
0
Rubella virus (RuV) is an enveloped, positive-sense single-stranded RNA virus that is pathogenic to humans. RuV binds to the target cell via the viral envelope protein E1, but the specific receptor molecules on the target cell are yet to be fully ...
More >
following
More protocols >
0 Protocol feedback
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.